TITLE

The use of cholesterol-lowering medications after coronary revascularization

AUTHOR(S)
Brophy, James M.; Bourgault, Chantal; Brassard, Paul
PUB. DATE
November 2003
SOURCE
CMAJ: Canadian Medical Association Journal;11/25/2003, Vol. 169 Issue 11, p1153
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: In clinical trials, cholesterol-lowering medications have been proven to decrease mortality and morbidity and are strongly recommended as secondary prevention for patients with established coronary artery disease. Whether physicians and patients follow this recommendation is unknown. Our objective was to determine the rate at which patients fill at least one prescription for cholesterol-lowering medications after coronary revascularization. Methods: Using the computerized administrative databases of the Régie de l'assurance maladie du Québec, we identified all elderly patients (older than 65 years) who had a coronary revascularization procedure (percutaneous coronary intervention or coronary artery bypass graft) between Apr. 1, 1995, and Dec. 31, 1997, and who survived until hospital discharge. We also determined the percentage of these patients who filled one or more prescriptions for cholesterol lowering drug therapy before Dec. 31, 1999, or death, whichever date came first. We used multivariate logistic regression models to examine the independent associations between filling a prescription for a cholesterol-lowering drug, patient characteristics and the type and year of coronary revascularization. Results: We identified 11 958 elderly patients who had a coronary revascularization between Apr. 1, 1995, and Dec. 31, 1997. During a follow-up period that averaged 3 years, 4443 (37.2%) patients did not fill a prescription for a cholesterol-lowering medication. Patients who were male, of advanced age, who had diabetes or congestive heart failure were less likely to fill a prescription for a cholesterol-lowering medication. Patients whose initial revascularization procedure was coronary artery bypass grafting were also less likely than those who had angioplasty to start cholesterol-lowering medication (relative risk...
ACCESSION #
11399387

 

Related Articles

  • Coronary artery disease and outcome in acute congestive heart failure. Purek, L.; Laule-Kilian, K.; Christ, A.; Klima, T.; Pfisterer, M. E.; Perruchoud, A. P.; Mueller, C. // Heart;May2006, Vol. 92 Issue 5, p598 

    Objectives: To quantify the prognostic impact of coronary artery disease (CAD) on patients with acute heart failure (HF). Design: Prospective cohort study of 217 consecutive patients presenting with acute HF to the emergency department. Treatment, hospitalisation, the use of revascularisation...

  • Revascularization in patients with heart failure. Tsuyuki, Ross T.; Shrive, Fiona M.; Galbraith, P. Diane; Knudtson, Merril L.; Graham, Michelle M. // CMAJ: Canadian Medical Association Journal;8/15/2006, Vol. 175 Issue 4, p361 

    Background: Although practice guidelines recommend coronary revascularization for patients with heart failure, the evidence to support this recommendation is weak. The objective of our study was to determine the association of coronary revascularization with survival in patients who have had...

  • Effect of Psychosocial Work Environment on Sickness Absence Among Patients Treated for Ischemic Heart Disease. Biering, Karin; Lund, Thomas; Andersen, Johan; Hjollund, Niels // Journal of Occupational Rehabilitation;Dec2015, Vol. 25 Issue 4, p776 

    No abstract available.

  • Methods in Measuring Return to Work: A Comparison of Measures of Return to Work Following Treatment of Coronary Heart Disease. Biering, Karin; Hjøllund, Niels; Lund, Thomas // Journal of Occupational Rehabilitation;Sep2013, Vol. 23 Issue 3, p400 

    Purpose Methods of measuring return to work (RTW) following temporary disability are diverse. The purpose of this study was to compare different measures of RTW within a 12-month period using a well-defined population of patients treated with Percutaneous Coronary Intervention (PCI) and weekly...

  • Risk Factors for Development of Septic Shock in Patients with Urinary Tract Infection. Hsiao, Chih-Yen; Yang, Huang-Yu; Chang, Chih-Hsiang; Lin, Hsing-Lin; Wu, Chao-Yi; Hsiao, Meng-Chang; Hung, Peir-Haur; Liu, Su-Hsun; Weng, Cheng-Hao; Lee, Cheng-Chia; Yen, Tzung-Hai; Chen, Yung-Chang; Wu, Tzu-Chin // BioMed Research International;8/25/2015, Vol. 2015, p1 

    Introduction. Severe sepsis and septic shock are associated with substantial mortality. However, few studies have assessed the risk of septic shock among patients who suffered from urinary tract infection (UTI). Materials and Methods. This retrospective study recruited UTI cases from an acute...

  • Statin utilization in nursing home patients after cardiac hospitalization. Parikh, Seema; Shrank, William; Mogun, Helen; Choudhry, Niteesh; Shrank, William H; Choudhry, Niteesh K // JGIM: Journal of General Internal Medicine;Dec2010, Vol. 25 Issue 12, p1293 

    Background: Coronary artery disease (CAD) is highly prevalent in nursing home residents and is associated with a substantial clinical and economic burden. Statins reduce mortality and hospitalization rates in older patients with CAD.Objectives: To assess rates and...

  • An examination of factors influencing the choice of therapy for patients with coronary artery disease. Hirani, Shashivadan P; Hyam, Jonathan A; Shaefi, Shahzad; Walker, John M; Walesby, Robin K; Newman, Stanton P // BMC Cardiovascular Disorders;2006, Vol. 6, p31 

    Background: A diverse range of factors influence clinicians' decisions regarding the allocation of patients to different treatments for coronary artery disease in routine cardiology clinics. These include demographic measures, risk factors, co-morbidities, measures of objective cardiac disease,...

  • T Wave Alternans Can Decrease After Coronary Revascularization. Batur, Mustafa Kemal; Oto, Ali; Ider, Ziya; Aksoyek, Serdar; Kabakci, Giray; Ovunc, Kenan; Tokgozoglu, Lale; Ozmen, Ferhan // Angiology;Aug2000, Vol. 51 Issue 8, p677 

    Determines the role of percutaneous transluminal coronary angioplasty-induced myocardial ischemia in the development of T wave alternans (TWA) and the effects of revascularization. Association of TWA with an increased propensity for ventricular fibrillation; Reduction of alternans with...

  • The Role of Coronary Angioplasty in the Management of Patients with Stable Coronary Artery Disease. Katritsis, Demosthenes G. // Cardiovascular & Haematological Disorders - Drug Targets;Mar2007, Vol. 7 Issue 1, p15 

    A review of the existing evidence on the impact of percutaneous coronary intervention (PCI) in the setting of stable coronary artery disease (CAD) indicates that in patients with chronic coronary artery disease and good left ventricular function, PCI does not confer any clear benefit in terms of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics